5 completed, 1 withdrawn. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow stearic acid: new trials by email Literature Review of stearic acid trials Research Report on stearic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects GS-441524, Placebo - COVID-19 | Phase 1 | Withdrawn | National Center for Advancing Translational Sciences (NCATS) | 2024-06-15 | 2025-02-14 | |
| A Randomized Phase 1 of of MZE001 in Healthy Volunteers MZE001, Placebo - Healthy | Phase 1 | Completed | Maze Therapeutics | 121 | 2022-02-07 | 2023-02-06 |
| Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients Cholecalciferol - Stable COPD Patients | Phase 1 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 48 | 2017-03-01 | 2019-01-10 |
| Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects Neurexan®, Placebo - Acute Stress Reaction | Phase 1 / Phase 2 | Completed | Biologische Heilmittel Heel GmbH | 66 | 2012-10-01 | 2015-02-11 |
| TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB Linezolid, Placebo - Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 36 | 2009-04-01 | 2026-07-06 |
| A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients Placebo, GW642444, Magnesium Stearate - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 24 | 2008-04-27 | 2017-08-10 |
Pulmonary Disease, Chronic Obstructive (2) · Anemia (1) · COVID-19 (1) · Extensively Drug-Resistant Tuberculosis (1) · Optic Nerve Diseases (1) · Peripheral Nervous System Diseases (1) · Stress Disorders, Traumatic, Acute (1) · Thrombocytopenia (1) · Tuberculosis, Multidrug-Resistant (1)
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Biologische Heilmittel Heel GmbH (1) · Centers for Disease Control and Prevention (1) · GlaxoSmithKline (1) · Maze Therapeutics (1) · National Center for Advancing Translational Sciences (NCATS) (1)
Australia (1) · Bangladesh (1) · Germany (1) · New Zealand (1) · South Africa (1) · United States (1)
Jussi Saukkonen, MD (1) · Manfred Schedlowski, PhD (1) · Nesri Padayachin, MBChB (1) · Philip E Sanderson, PhD (1) · Samia Hassan (1) · Sarah Noonberg, MD (1) · Waffa El-Sadr, MD (1)